239 filings
6-K
CYBN
Cybin Inc.
18 Apr 24
Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry
3:12pm
6-K
CYBN
Cybin Inc.
18 Apr 24
Current report (foreign)
9:03am
SUPPL
CYBN
Cybin Inc.
18 Apr 24
Supplemental materials (foreign)
8:50am
6-K
CYBN
Cybin Inc.
16 Apr 24
Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive Disorder
3:36pm
F-10POS
CYBN
Cybin Inc.
10 Apr 24
Automatic registration of securities (post-effective amendment, Canada)
8:35pm
6-K
CYBN
Cybin Inc.
10 Apr 24
Cybin to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
5:23pm
D
CYBN
Cybin Inc.
3 Apr 24
$108.70 mm in equity, sold $108.70 mm, 12 investors
1:08pm
SC 13G
CYBN
Cybin Inc.
25 Mar 24
CYBIN / RA CAPITAL MANAGEMENT ownership change
4:17pm
SC 13G
Deep Track Capital, LP
22 Mar 24
CYBIN / Deep Track Capital ownership change
4:02pm
6-K
CYBN
Cybin Inc.
22 Mar 24
Material Change Report
2:41pm
6-K
CYBN
Cybin Inc.
21 Mar 24
Current report (foreign)
1:55pm
6-K
CYBN
Cybin Inc.
20 Mar 24
Announces Oversubscribed Private Placement of U.S. $150 Million
3:16pm
6-K
CYBN
Cybin Inc.
18 Mar 24
Cybin to Present at Public Ventures Discovery Day on March 19th in Dallas
2:49pm
6-K
CYBN
Cybin Inc.
15 Mar 24
Current report (foreign)
3:19pm
6-K
CYBN
Cybin Inc.
14 Mar 24
Cybin Announces Positive End-of-Phase 2 Meeting with FDA for CYB003 in Major Depressive Disorder and Phase 3 Program Design
3:59pm
6-K
CYBN
Cybin Inc.
13 Mar 24
Current report (foreign)
4:09pm
6-K
CYBN
Cybin Inc.
13 Mar 24
Cybin to Host Conference Call and Webcast to Provide Program Update for CYB003
3:38pm
6-K
CYBN
Cybin Inc.
27 Feb 24
Cybin to Present at the TD Cowen 44th Annual Health Care Conference
1:34pm
6-K/A
CYBN
Cybin Inc.
15 Feb 24
Condensed Interim Consolidated Financial Statements
11:09am
SC 13G/A
CYBN
Cybin Inc.
14 Feb 24
CYBIN / Point72 Asset Management ownership change
4:14pm